论文部分内容阅读
美国食品药品管理局(FDA)发布信息,静脉用抗菌药cubicin(达托霉素)治疗期间可能发生嗜酸性粒细胞性肺炎。达托霉素2003年被批准用于治疗严重皮肤感染,2006年被批准用于治疗血流感染。嗜酸性粒细胞性肺炎是一种罕见、但严重的疾病,表现
The U.S. Food and Drug Administration (FDA) released information that eosinophilic pneumonia may occur during intravenous antibiotic treatment with cubicin (daptomycin). Daptomycin approved in 2003 for the treatment of severe skin infections was approved in 2006 for the treatment of bloodstream infections. Eosinophilic pneumonia is a rare but serious disease that manifests itself